Healthcare -
Biotechnology - NASDAQ - US
$ 0.2069
-3.32 %
$ 13.5 M
Market Cap
-0.14
P/E
LYRA - SHORT-TERM DEBT
Short-term Debt LYRA - Lyra Therapeutics, Inc.
8.91 M
LAST VALUE
103.63%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR